COVID-19 pandemic
The Health Sciences Authority approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years, with vaccine rollout for this age group to begin before the end of the year.
Sources: CNA
Changes
- The Health Sciences Authority approves the usage of the Pfizer-BioNTech COVID-19 vaccine for children aged 5 to 11 years, with the inoculation set to begin before the end of the year.
- The Health Sciences Authority approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years, with vaccine rollout for this age group to begin before the end of the year.